GEMSTONE Oncology logo
MenuClose

Use of Clinical Trials in Expanding Treatment for Ovarian Cancer

  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide
  • slide

Download Slide Module

Clinical trials drive advances in ovarian cancer treatment.

Clinical trials are critical in advancing the science of cancer care, but the value of clinical trial outcomes depends on careful:

  • Design and implementation

  • Attention to statistical parameters

  • Determination of patient selection criteria based on assessment of the benefit:risk ratio

Patients and their doctors must carefully discuss the details of the study. With transparent dialogue, the patient can ultimately make an informed decision before participating in a clinical trial. 

Explore the module further to learn more about the use of clinical trials in expanding treatment options for ovarian cancer—or download the module for later review offline.

Well-designed clinical trials based on robust preliminary data are critical to advance treatment of ovarian cancer. By participating in clinical trials, patients can help clinical investigators improve the standard of care.

ROBERT A. BURGER, MD, FACOG, FACS
University of Pennsylvania
GEMSTONE Committee Member: Robert A. Burger, MD, FACOG, FACS
GEMSTONE Oncology infographic ‐ clinical trials help drive advances in ovarian cancer treatment

Download Infographic